Platelet monitoring in 165 patients treated with heparin
Chagnon, A.; Dalger, J.; Souchet, T.; Woringer, P.; Carpentier, D.
La Nouvelle Presse Medicale 11(50): 3731-3732
1982
ISSN/ISBN: 0301-1518 PMID: 7170181 Document Number: 187732
Document emailed within 1 workday
Related Documents
Mak, K.H.; Kottke-Marchant, K.; Brooks, L.M.; Topol, E.J. 1998: In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia Thrombosis and Haemostasis 80(6): 989-993White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Chong, B.H.; Pitney, W.R.; Castaldi, P.A. 1982: Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation Lancet 2(8310): 1246-1249
Knudsen, F.; Kristensen, S.D.; Nielsen, A.H.; Ring, T.; Stoffersen, E. 1985: Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction? Clinical Nephrology 23(2): 107
Venakatachalapathy, T.S.; Mohan Kumar, S.; Saliba, M.J. 2007: A comparative study of burns treated with topical heparin and without heparin Annals of Burns and Fire Disasters 20(4): 189-198
Bacher, P.; Horst, B.; Breyer, H.G.; Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1993: Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patients Seminars in Thrombosis and Hemostasis 19(Suppl 1): 73-78
Belmin, J.; Medjahed, S.; Trivalle, C.; Lutzler, P. 2001: Heparin use in geriatrics and risk profiles of treated patients. a survey in France Presse Medicale 30(3): 101-106
von Felten, A. 1992: Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex Therapeutische Umschau. Revue Therapeutique 49(12): 837-842
Hortin, G.L.; Cole, T.G.; Gibson, D.W.; Kessler, G. 1988: Decreased stability of triglycerides and increased free glycerol in serum from heparin-treated patients Clinical Chemistry 34(9): 1847-1849
Borowska, A.; Bachórzewska-Gajewska, H.; Kaliciński, A. 1986: Platelet aggregation in patients with hyperlipoproteinemia treated with bezafibrate Polski Tygodnik Lekarski 41(9): 273-276
Cohen, M. 2000: Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes Journal of Invasive Cardiology 12 Suppl E: E5
Sturm, D.; Vazdar, L.; Bagatin, D.; Sakic, K.; Hrgovic, Z. 2012: Perioperative PAI-1 values in surgically treated colorectal carcinoma patients under low molecular weight heparin thromboprophylaxis Minerva Chirurgica 67(4): 343-354
Combes, V.; Joly, P.; Ambrosi, P.; Sabatier, F.; Camoin, L.; Pili, J.; Sampol, J.; Dignat-George, F. 2000: Platelet vesiculation in angina patients treated with coronary angioplasty Thrombosis and Haemostasis 83(3): 518
Barrellier, M.T.; Le Hello, C.; Verfaille, M.; Vignon, C.; Bertin, T.; Boissel, M.; Dubois, F.; Fauchon, G.; Pegoix, M.; Thomassin, C.; Trahay, A.; Aubriot, J.H.; Vielpeau, C. 2000: Echo-doppler monitoring of asymptomatic distal deep vein thrombosis in patients given low-molecular-weight-heparin at prophylactic doses after orthopedic surgery Journal des Maladies Vasculaires 25(3): 195-200
Barradas, M.A.; Stansby, G.; Hamilton, G.; Mikhailidis, D.P. 1994: Diminished platelet yield and enhanced platelet aggregability in platelet-rich plasma of peripheral vascular disease patients International Angiology: a Journal of the International Union of Angiology 13(3): 202-207
Rozo, L.; Carlier, R.; Fumoleau, P.; Nicolas, G. 1981: Non-invasive methods in the monitoring of patients treated with adriamycin Archives des Maladies du Coeur et des Vaisseaux 74(11): 1341-1348
Chatenoud, L.; Ferran, C.; Bach, J.F. 1990: In vivo use of OKT3: main issues for the monitoring of treated patients Transplantation Proceedings 22(6): 2605-2608
Masselot, J.P.; Adhemar, J.P.; Laederich, J.; Degoulet, P.; Kleinknecht, D. 1979: Use of the DIAPHANE information system for the monitoring of patients treated by home hemodialysis Journal d'Urologie et de Nephrologie 85(12): 963-969
Marcus E Carr; Jr.; Martin, E.J.; Kuhn, J.G.; Ambrose, H.; Fern, S.; Bryant, P.C. 2004: Monitoring of Hemostatic Status in Four Patients Being Treated with Recombinant Factor Vlla Clinical Laboratory 50(9-10): 529-538
Barrett, P.A.; Butler, K.D.; Morley, J.; Page, C.P.; Paul, W.; White, A.M. 1984: Inhibition by heparin of platelet accumulation in vivo Thrombosis and Haemostasis 51(3): 366-370